KZR Overview
Upcoming Projects (KZR)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (KZR)
-
A Second Opinion: Looking at the topline results of the Phase 2 MISSION trial of zetomipzomib in Lupus Nephritis patients
Tickers: KZR, GSK, AUPH
Executed On: Sep 01, 2022 at 01:00 PM EDT -
A look at the topline results of the Phase 2 MISSION trial of zetomipzomib in Lupus Nephritis patients
Tickers: KZR, AUPH
Executed On: Jun 30, 2022 at 02:00 PM EDT
Expired Projects (KZR)
-
Discussing Kezar’s Zetomipzomib trial in Lupus Nephritis following recently released phase 2 results
Ticker: KZR
Execute By: Aug 23, 2022 -
A Third View: Discussing the interim results from the MISSION phase 2 trial of KZR-616 in treating lupus nephritis
Ticker: KZR
Execute By: Dec 17, 2021
Upcoming & Overdue Catalysts (KZR)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (KZR)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
